(a)
(b)
(c)
Figure 4: Analysis of tissue response following subcutaneous implantation of BPCM and DFDBCBM. There was no significant difference in capsule quantity (a), capsule quality (b), and interface quality (c) between the two groups throughout the observed healing periods.